Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Member sign in
Join redeye
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
The latest from Redeye about Scandinavian Life Science and Technology companies
LIDDS
Potential longer-lasting effect
Alzinova
Aducanumab (Biogen) buried alive
Lagercrantz Group
Q2’19/20: Som väntat på gruppnivå
BioArctic
Konfidenshöjande återuppståndelse
Christian Berner Tech Trade
Starkt från Materialteknik – Stororder flyttad till H1 2020
Enea
Sales as expected - weaker gross margin
Xvivo Perfusion
Q3 expectations
TagMaster
Q3’19 preview - important checkpoint
Nanologica
Lån stärker kassan
AroCell
Raising capital
AroCell
Videointervju med vd Michael Brobjer och CFO Anders Hultman
Moberg Pharma
Major inflection points approaching
Idogen
Q3 review
Orexo
Våra förväntningar inför Q3-rapporten
Q-linea
Pivotal trial postponed
Transactions
09
Oct
Acarix genomför företrädesemission
Events
24
Oct
Investor After Work Göteborg
25
Oct
Orexo: Investor Lunch
05
Nov
Aspire Global Live-Q 5 Nov
05
Nov
Enlabs Live-Q 5 Nov
05
Nov
Investor Forum
05
Nov
AroCell: Live Quarterly Presentation and Q&A
Announcements
Redeye söker Projektledare inom Corporate Finance
Vill du bli vår IT-support?
New accounting principle to affect upcoming interim reports